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OBJECTIVES This study sought to quantify the effect of body mass index (BMI) on early clinical outcomes
following coronary artery bypass grafting (CABG).
BACKGROUND Obesity is considered a risk factor for postoperative morbidity and mortality after cardiac
surgery, although existing evidence is contradictory.
METHODS A concurrent cohort study of consecutive patients undergoing CABG from April 1996 to
September 2001 was carried out. Main outcomes were early death; perioperative myocardial
infarction; infective, respiratory, renal, and neurological complications; transfusion; duration
of ventilation, intensive care unit, and hospital stay. Multivariable analyses compared the risk
of outcomes between five different BMI groups after adjusting for case-mix.
RESULTS Out of 4,372 patients, 3.0% were underweight (BMI 20 kg/m2), 26.7% had a normal
weight (BMI 20 and 25 kg/m2), 49.7% were overweight (BMI 25 and 30 kg/m2),
17.1% obese (BMI 30 and 35 kg/m2) and 3.6% severely obese (BMI 35 kg/m2).
Compared with the normal weight group, the overweight and obese groups included more
women, diabetics, and hypertensives, but fewer patients with severe ischemic heart disease
and poor ventricular function. Underweight patients were more likely than normal weight
patients to die in hospital (odds ratio [OR]  4.0, 95% CI 1.4 to 11.1), have a renal
complication (OR  1.9, 95% confidence interval [CI] 1.0 to 3.7), or stay in hospital longer
(7 days) (OR  1.7, 95% CI 1.1 to 2.5). Overweight, obese, and severely obese patients
were not at higher risk of adverse outcomes than normal weight patients, and were less likely
than normal weight patients to require transfusion (ORs from 0.42 to 0.86).
CONCLUSIONS Underweight patients undergoing CABG have a higher risk of death or complications than
normal weight patients. Obesity does not affect the risk of perioperative death and other
adverse outcomes compared to normal weight, yet obese patients appear less likely to be
selected for surgery than normal weight patients. (J Am Coll Cardiol 2003;42:668–76)
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Over recent decades, improvement of socioeconomic con-
ditions has led to an expansion of the overweight population
worldwide. Obesity is well known to be a risk factor for the
development of diabetes mellitus, hypertension, and coro-
nary artery disease (1–3). It is also thought to be a risk factor
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for perioperative morbidity and mortality with cardiac
surgery, evidenced by its inclusion in the Parsonnet system
for stratification of risk for perioperative death (4). The
latest analysis of the National Cardiac Surgery Database of
the Society of Thoracic Surgeons, using data from coronary
artery bypass grafting (CABG) operations in over 300,000
patients, indicated that morbid obesity remains an indepen-
dent predictor of increased operative mortality in patients
undergoing CABG (5).
Most studies assessing the effect of body mass index
(BMI) on early clinical outcome after CABG have com-
pared hospital mortality and morbidity between obese and
non-obese patients (6,7). Grouping patients in this way
means that each group includes patients with widely varying
BMIs, which, in turn, may mask the true effects of varying
BMI on outcome (8). Many previous attempts to address
this problem have been limited by small sample sizes or a
lack of data about potentially confounding factors (6–8).
The aim of this paper is to study the effect of varying
BMI on early clinical outcome in patients undergoing
CABG. The use in our institution of a high-quality pro-
spective database to document all patients undergoing
coronary revascularization, including data about potentially
confounding factors, created the opportunity to address this
research question using a cohort study design without the
limitations experienced by previous researchers (6–8).
METHODS
Patient selection and data collection. Standard data are
collected prospectively for all patients undergoing CABG at
our institution. The data collection form includes five
sections that are filled in consecutively by anesthetist,
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surgeon, intensive care unit (ICU), high dependency unit
(HDU), and ward nurses. Data are entered into a database
(Patient Analysis & Tracking System, Dendrite Clinical
Systems, London, United Kingdom). For this study, data
were extracted from the database for consecutive patients
who had undergone CABG between April 1996 and Sep-
tember 2001. During this period, some surgeons adopted an
off-pump surgical technique for many patients; all patients,
whether undergoing surgery with cardiopulmonary bypass
or off-pump, are included.
Cardiac catheterization was performed using standard
methods during the course of routine clinical care. Angiog-
raphy reports were reviewed before surgery to assess the
severity of coronary artery disease, expressed as the number
of diseased vessels. Priority of surgery was assessed by the
cardiothoracic surgeon and was defined as follows: emer-
gency (the surgery should be performed within hours to
prevent morbidity or death), urgent (medical factors require
the patient to stay in hospital waiting for an operation),
elective (the clinical status of the patient allows discharge
from hospital with readmission for surgery at a later date).
Surgical technique and postoperative management.
Anesthetic and surgical techniques were standardized for all
patients and have been previously reported (9,10). At the
end of surgery, patients were transferred to the ICU and
were extubated as soon as they met the following criteria:
hemodynamic stability, no excessive bleeding (80 ml/h),
normothermia, and consciousness with pain control. Post-
operatively, fluid management and electrolyte deficiency
were managed as previously reported (9).
Clinical data collection, monitoring, and definitions.
Data were entered prospectively into the Patient Analysis &
Tracking System. The research question was posed after the
collection of the data but before any data analysis. Periop-
erative death was defined as any death occurring within 30
days of operation (regardless of where the death occurred) or
in hospital (in patients who had not been discharged
following the operation). Perioperative myocardial infarc-
tion, ST segment changes, pacing, arrhythmias, and inotro-
pic requirement were recorded and defined as previously
reported (9). Pulmonary complication included chest infec-
tion, ventilation failure, reintubation, and tracheostomy.
Postoperative blood loss was defined as total chest tube
drainage (11). Neurological complication included perma-
nent and transient stroke (12) and Glasgow Coma Score
15 without sedation. Renal complication included post-
operative creatinine 200 mol/l and acute renal failure as
defined by the requirement of hemodialysis. Finally, infec-
tive complication included septicemia and sternal and leg
wound infection as defined by positive culture and requiring
antibiotic therapy (9).
Statistical analysis. Of the commonly used measures of
obesity, BMI (defined as kg/m2) is the body size measure-
ment that best correlates with body fat content (13). Body
mass index values were categorized into one of five groups:
underweight (20 kg/m2); normal weight (20 and 25
kg/m2); overweight (25 and 30 kg/m2); obese (30 and
35 kg/m2); severely obese (35 kg/m2). These groups
were based, in part, on criteria specified by the American
Heart Association guidelines for defining overweight (3).
Additional groups—i.e., the underweight, normal weight,
and severely obese—were included to characterize the entire
BMI range. We chose not to analyze BMI as a continuous
variable because this would have required making assump-
tions about underlying relationships between BMI and the
clinical outcomes investigated in order to carry out multi-
variable modeling.
Continuously or discretely measured prognostic variables
(age, Parsonnet score, number of grafts) and outcomes
(blood loss; red blood cell, platelet, and fresh frozen plasma
transfusion; postoperative hemoglobin levels; duration of
ventilation, ICU stay, combined ICU and HDU stay, and
total postoperative stay) were also grouped for analysis. All
continuously or discretely measured outcomes were dichot-
omized for multivariable analyses.
Comparisons of the distributions of prognostic factors
among BMI groups were carried out using chi-square or
Fisher’s exact tests when one or more expected frequency
was 5. All comparisons of outcome among BMI groups
were carried out using logistic regression modeling to take
into account the consultant team responsible for a patient.
(The four consultant teams were modeled as “fixed” effects
using indicator variables.) Likelihood ratio tests were used
to determine the probability of overall distributions of
outcomes across BMI groups having arisen by chance.
Regression models also estimated odds ratios (ORs) and
95% confidence intervals for the effects of underweight,
overweight, obesity, and severe obesity compared with
normal weight on the outcomes of interest.
Five propensity scores (describing the probability of
classification into each BMI group as a function of all
prognostic factors and year of operation) were derived using
polytomous logistic regression, to take account of imbal-
ances in the distribution of prognostic factors between BMI
groups (14). Logistic regression models were then fitted
including the five propensity scores divided into quintiles,
consultant team, and BMI group. Additional models, in-
cluding key prognostic factors as well as the propensity
scores, were investigated, but they are not reported here
because they did not alter the estimates of effect of BMI
group (15). The large number of prognostic variables and
outcomes of interest resulted in many statistical compari-
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sons. No correction was made for multiple comparisons.
Our interpretation of the findings is based on the consis-
tency of the findings and their magnitude, as well as their
statistical significance. All analyses were carried out using
STATA version 7 (Stata Corporation, College Station,
Texas).
RESULTS
A total of 4,467 patients underwent CABG (25.3% off-
pump surgery) during the study period, but BMI was
missing or invalid for 95 (2.1%). Of the remaining 4,372,
133 (3.0%) were classified as underweight, 1,166 (26.7%) as
normal weight, 2,170 (49.7%) as overweight, 747 (17.1%) as
obese, and 156 (3.6%) as severely obese. Data for prognostic
factors were missing for a small number of patients (1.0%
of patients for any single prognostic factor), preventing the
calculation of propensity scores for 112 (2.6%) of the 4,372
patients. Outcomes were also occasionally missing (1.2%
of patients for any single outcome, except for blood loss and
transfusion requirements; these latter data were not col-
lected from April 1996 to March 1997 but were available for
97.5% of patients undergoing CABG from April 1997).
Comparisons of risk factors between BMI groups. The
distributions of a wide range of prognostic characteristics in
the five BMI groups are shown in Table 1. It is striking that
the majority of prognostic factors were distributed unequally
across BMI groups. Some variables showed a steady change
across groups, with the overweight and obese groups having
a more favorable risk profile—e.g., fewer older patients,
fewer patients with left main stem stenosis 50%, lower
Parsonnet score, higher ejection fraction, less extensive
coronary disease (trend tests across BMI groups all signifi-
cant p  0.001). Only two variables, the proportion of
females and the prevalence of hypercholesterolemia, showed
a clear trend in the opposite direction, i.e., the frequency of
the risk factor increased with increasing obesity (trend test p
 0.001). Some variables had inverted U-shape distribu-
tions, with risk factors being more common at both ex-
tremes of BMI—e.g., prevalence of unstable angina, diabe-
tes, and hypertension. Two risk factors, creatinine 200
mol/l and prevalence of chronic obstructive airways dis-
ease, were more prevalent in the underweight group and
appeared similarly distributed across the other groups (trend
tests p  0.001 and p  0.13, respectively).
Comparisons of early clinical outcomes between BMI
groups. The distributions of early clinical outcomes are
shown in Table 2. Likelihood tests showed that several
outcomes were distributed unequally between BMI groups.
Odds ratios for each outcome for different BMI groups
relative to the normal weight group are tabulated in Table 3,
and key outcomes are shown graphically in the figures (Fig.
1: death, complications, and blood loss; Fig. 2: markers of
delayed recovery following surgery). The figures show ORs
before and after taking account of imbalances in prognostic
factors between groups using the propensity scores. Ad-
justed estimates tended to be closer to the line of no effect
(OR  1), but it is notable that the overall profiles of the
likelihood of outcomes as a function of BMI were largely
unaltered by adjustment.
The likelihood of complications as a function of BMI in
the underweight, overweight, obese, and severely obese
groups tended either to be uniform and not significantly
different compared to the normal weight group (e.g., neu-
rological complication, postoperative chest infection) or to
be raised for the underweight group and not significantly
different from the normal weight group for overweight and
obese groups (e.g., perioperative death, need for an intra-
aortic balloon pump) (Fig. 1, Table 3). The latter type of
profile across BMI groups was also shown for perioperative
myocardial infarction and postoperative renal complication
(Table 3), but the OR estimates for the underweight group,
although substantially higher than unity (1.92 and 1.58,
respectively) were not significantly different from unity (OR
 1). These comparisons had low power to detect differ-
ences between groups because of the paucity of events.
Odds ratios for blood loss and transfusion requirement
across BMI groups (Fig. 1, Table 3) show that overweight
and obese patients tend to be protected against these
outcomes compared with normal weight patients, with
underweight patients having the same odds of these out-
comes as normal weight patients. This tendency was clearly
significant for postoperative blood loss 1,000 ml and the
need for transfusion of platelets or fresh frozen plasma. The
finding that obese patients were more likely to have a
postoperative hemoglobin level 10 mg/dl was consistent
with the lower odds of transfusion of platelets or fresh
frozen plasma in these patients.
With respect to indicators of overall recovery, under-
weight patients appeared to recover less quickly than normal
weight patients. They were more likely to be ventilated for
10 h, tended to require an ICU stay 1 night, and were
more likely to stay in hospital 7 days. There was a
suggestion from the ORs for these outcomes that obese and
severely obese patients were also more likely than normal
weight patients to stay in hospital 7 days.
DISCUSSION
Our study has two main findings. First, obese patients do
not experience greater morbidity and mortality than normal
weight patients after CABG after taking account of imbal-
ances in key prognostic factors. The overweight group did
not have significantly worse outcomes than the normal
weight group for any of the adverse outcomes studied.
Obese and severely obese groups fared worse than the
normal weight group only with respect to the likelihood of
staying in hospital 7 days after the operation. In contrast,
underweight patients appeared to have a higher risk of death
and common complications and to recover more slowly.
Second, in our institution, obese patients with severe
ischemic heart disease (e.g., extent of coronary disease,
670 Reeves et al. JACC Vol. 42, No. 4, 2003
Effect of BMI After Coronary Surgery August 20, 2003:668–76
Table 1. Distribution of Prognostic Variables in Underweight, Normal Weight and Overweight Groups of Increasing BMI
at Admission
Prognostic Variable
Underweight
(n  133)
(BMI <20)
Normal
(n  1,166)
(BMI >20
& <25)
Overweight
(n  2,170)
(BMI >25
& <30)
Obese
(n  747)
(BMI >30
& <35)
Severely
Obese
(n  156)
(BMI >35)
p
Value*n % n % n % n % n %
Age at surgery (yrs)
16 & 45 4 3.0 28 2.4 57 2.6 24 3.2 5 3.2  0.001
45 & 55 1 0.8 122 10.5 347 16.0 135 18.1 30 19.2
55 & 65 13 9.8 320 27.4 805 37.1 284 38.0 65 41.7
65 & 75 58 43.6 551 47.3 833 38.4 274 36.7 52 33.3
75 57 42.9 145 12.4 128 5.9 30 4.0 4 2.6
Male 105 79.0 984 84.4 1,855 85.5 527 70.6 74 47.4  0.001
CCS class
2 38 28.6 430 36.9 845 39.1 280 37.5 36 23.1 0.001
3 45 33.8 403 34.6 707 32.7 270 36.1 72 46.2
4 50 37.6 331 28.4 612 28.3 197 26.4 48 30.8
NYHA class
1 19 14.3 295 25.3 471 21.8 124 16.6 16 10.3  0.001
2 59 44.4 495 42.5 938 43.4 340 45.5 66 42.3
3 41 30.8 319 27.4 642 29.7 250 33.5 67 43.0
4 14 10.5 56 4.8 113 5.2 33 4.4 7 4.5
Unstable angina 71 53.4 525 45.2 891 41.2 292 39.1 73 46.8 0.003
Previous MI 60 45.1 518 44.4 946 43.8 338 45.3 72 46.2 0.94
Diabetes 27 20.3 170 14.6 315 14.6 138 18.5 44 28.2  0.001
Hypercholesterolemia 82 62.6 810 69.7 1,586 73.5 584 78.2 129 82.7  0.001
Hypertension 83 62.4 652 55.9 1,196 55.3 458 61.4 100 64.1  0.001
Current smoker 11 8.3 144 12.4 264 12.2 109 14.6 19 12.2 0.25
Creatinine 200 mol/l 8 6.0 20 1.7 34 1.6 4 0.5 1 0.6 0.001
Preoperative COAD 15 11.3 54 4.6 99 4.6 36 4.8 6 3.9 0.01
Previous CVA 14 10.5 109 9.4 166 7.7 58 7.8 9 5.6 0.26
Preoperative LMS 50% 20 15.0 149 12.8 279 12.9 91 12.2 11 7.1  0.001
Preoperative peripheral vascular disease 16 12.0 106 9.1 206 9.5 61 8.2 9 5.8 0.32
Parsonnet score  0.001
0–10 38 28.6 850 72.9 1,842 84.9 649 86.9 130 83.3
11–20 84 63.2 293 25.1 305 14.1 91 12.2 24 15.4
20 11 8.3 23 2.0 23 1.1 7 0.9 2 1.3
Ejection fraction 0.002
50% 82 63.1 786 67.9 1,570 72.9 560 75.6 112 72.3
30% & 50% 36 27.7 298 25.7 483 22.4 152 20.5 38 24.5
30% 12 9.2 74 6.4 101 4.7 29 3.9 5 3.2
Extent of coronary disease 0.04
Single vessel 9 6.8 78 6.7 156 7.2 58 7.8 16 10.3
Double vessel 20 15.0 270 23.2 546 25.2 201 26.9 45 28.9
Triple vessel 104 78.2 818 70.2 1,468 67.7 488 65.3 95 60.9
Operative priority 0.01
Elective 46 34.6 489 42.0 1,024 47.2 346 46.4 69 44.2
Urgent 63 47.4 512 44.0 873 40.3 300 40.3 73 46.8
Emergency 24 18.1 164 14.1 271 12.5 99 13.3 14 9.0
Number of grafts 0.006
1 13 9.8 90 7.7 166 7.7 61 8.2 12 7.7
2 29 21.8 278 23.9 580 26.7 217 29.1 57 36.5
3 65 48.9 562 48.2 990 45.6 358 47.9 69 44.2
4 26 19.6 235 20.2 433 20.0 111 14.9 18 11.5
Off-pump surgery 35 26.3 262 22.5 546 25.2 215 28.8 50 32.1 0.009
Numbers do not always sum to the totals for each BMI group because there were missing data for some prognostic factors (1% for any variable). *p values for chi-squared or
Fisher’s exact tests.
BMI  body mass index; CCS  Canadian Cardiovascular Society; COAD  chronic obstructive airways disease; CVA  cerebro-vascular accident; LMS  left main stem
stenosis; MI  myocardial infarction; NYHA  New York Heart Association.
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Table 2. Distributions of Early Clinical Outcomes in Underweight, Normal Weight and Overweight Groups of Increasing BMI
Outcome
Underweight
(n  133)
(BMI <20)
Normal
(n  1,166)
(BMI >20
& <25)
Overweight
(n  2,170)
(BMI >25 &
<30)
Obese
(n  747)
(BMI >30
& <35)
Severely
Obese
(n  156)
(BMI >35)
p
Value*n % n % n % n % n %
Death 9 6.8 11 0.9 18 0.8 6 0.8 1 0.6 0.001†
Perioperative MI 4 3.0 23 2.0 38 1.8 12 1.6 2 1.3 0.58†
Postoperative inotropic support 62 46.6 510 44.0 819 38.0 294 39.5 57 36.8 0.005
Postoperative IABP 11 8.3 33 2.9 47 2.2 14 1.9 2 1.3 0.002†
Postoperative arrhythmia 31 23.3 200 17.3 325 15.1 98 13.3 21 13.6 0.02
Postoperative VF or VT 4 3.0 25 2.2 27 1.3 9 1.2 1 0.7 0.08†
Pulmonary complication 23 17.3 136 11.7 235 10.9 88 11.8 17 11.0 0.29
Chest infection 9 6.8 62 5.4 101 4.7 33 4.5 5 3.2 0.56
Neurological complication 2 1.5 25 2.2 59 2.7 12 1.6 1 0.7 0.13†
Permanent stroke 0 0.0 6 0.5 11 0.5 5 0.7 0 0.0 0.98†
Transient stroke 2 1.5 4 0.4 12 0.6 4 0.5 0 0.0 0.42†
Infective complication 9 6.8 20 1.7 50 2.3 21 2.8 4 2.6 0.03
Septicemia 5 3.8 8 0.7 19 0.9 11 1.5 1 0.7 0.03†
Renal complication 17 12.8 56 4.8 104 4.8 30 4.0 5 3.2 0.004
Dialysis required 6 4.5 21 1.8 17 0.8 6 0.8 1 0.7 0.001†
Multisystem failure 8 6.0 6 0.5 9 0.4 6 0.8 0 0.0  0.001†
Sternal rewiring/mediastinitis 1 0.8 7 0.6 17 0.8 6 0.8 0 0.0 0.83‡
Reoperation for bleeding or tamponade 6 4.5 58 5.0 75 3.5 15 2.0 5 3.2 0.01
Blood loss (ml)  0.001
500 19 14.3 120 10.4 250 11.6 135 18.3 37 23.7
500 & 1,000 54 40.6 412 35.6 815 37.9 276 37.4 68 43.6
1,000 & 2,000 33 24.8 302 26.1 534 24.8 144 19.5 18 11.5
2000 27 20.3 323 27.9 553 25.7 183 24.8 33 21.2
Total RBC transfusion (U)  0.001
0 44 37.3 477 50.7 1,054 59.3 380 62.1 79 60.8
1–2 45 38.1 306 32.6 524 29.5 171 28.9 38 29.2
3 29 24.6 157 16.7 200 11.3 55 9.0 13 10.0
Total platelet transfusion (U)  0.001
0 92 78.6 735 78.7 1,533 86.2 556 91.2 118 92.2  0.001
1–2 21 18.0 161 17.2 212 11.9 48 7.9 10 7.8
3 4 3.4 38 4.1 33 1.9 6 1.0 0 0.0
Any fresh frozen plasma transfusion 22 18.6 151 16.1 205 11.6 38 6.2 6 4.6  0.001
Postoperative hemoglobin 10 g/dl 45 40.5 359 38.4 701 39.6 256 42.0 59 45.4 0.36
Hours ventilated  0.001
0–5 16 12.2 254 22.0 572 26.7 203 27.6 52 34.0
6–10 49 37.4 468 40.6 890 41.5 295 40.1 45 29.4
11–20 39 29.8 327 28.3 518 24.2 177 24.1 38 24.8
20 27 20.6 105 9.1 165 7.7 60 8.2 18 11.8
ITU stay (nights)
0 8 6.0 62 5.3 149 6.9 61 8.2 12 7.7 0.03
1 81 60.9 819 70.6 1,534 71.1 520 69.7 102 65.4
2 23 17.3 138 11.9 247 11.4 95 12.7 24 15.4
3 9 6.8 71 6.1 128 5.9 38 5.1 11 7.1
4 12 9.0 70 6.0 101 4.7 32 4.3 7 4.5
ITU & HDU stay (nights)
1 7 5.3 88 7.7 175 8.2 66 8.9 16 10.5 0.11
2 60 45.1 480 41.8 968 45.2 342 46.2 60 39.2
3 22 16.5 252 21.9 463 21.6 164 22.2 34 22.2
4 16 12.0 159 13.8 248 11.6 84 11.4 21 13.7
5 28 21.1 170 14.8 288 13.5 84 11.4 22 14.4
Total length of stays (days) 0.02
0–7 69 55.7 798 69.3 1,496 69.7 503 68.0 101 65.2
8–10 42 33.9 205 17.8 401 18.7 142 19.2 30 19.4
11–15 9 7.3 98 8.5 157 7.3 61 8.2 14 9.0
16 4 3.2 50 4.3 91 4.2 34 4.6 10 6.5
Numbers do not always sum to the totals for each BMI group because there were missing data for some outcomes (1.3% for any variable except postoperative blood loss and
transfusion requirement; the latter variables were not collected during the first year of data collection). *p values for overall effect of differences in outcome between BMI groups,
based on a logistic regression model adjusting for the fixed effects of consultant team. A significant overall effect does not imply all pairwise comparisons between groups are
significant, and some differences between pairs of groups can be significant even when the overall effect is not. Outcomes shown as having multiple categories were analyzed as
dichotomous variables, as described in Table 3 and in the figures. †The two highest BMI groups were combined for the logistic regression analysis because of the small number
of events in the highest BMI group. ‡The two highest and the two lowest BMI groups were combined for the logistic regression analysis because of the small number of events in the
lowest and highest BMI groups. §Excluding length of stay for 21 patients who died in hospital.
BMI  body mass index; HDU  high dependency unit; IABP  intra-aortic balloon pump; ITU  intensive therapy unit; MI  myocardial infarction; RBC  red blood cells;
VF  ventricular fibrillation; VT  ventricular tachycardia.
ejection fraction, left main stem stenosis; Table 1) are
relatively under-represented among patients undergoing
CABG. Conversely, there appears to be a relative excess of
low-weight patients with severe ischemic heart disease and
important comorbidities who needed urgent or emergency
CABG.
Study limitations. Without blinding, assessment of some
outcomes could have been biased by knowledge of the BMI
of patients, e.g., obese patients may have been kept in
hospital longer as a precaution. In our institution, strict local
guidelines are used to make decisions about perioperative
patient care management; these guidelines were applied
carefully throughout the period of the study and minimized
the susceptibility of outcomes to bias. Moreover, given the
prevailing view that obesity is a risk factor for poor outcome
(4,5,16), such biases would have resulted in the overweight
and obese groups appearing to be more at risk than in fact
they were. Therefore, bias cannot explain why we did not
observe an increase in the risk of mortality and morbidity in
overweight and obese patients, although it may explain why
obese and severely obese patients were more likely to stay in
hospital 7 days.
The BMI groups consisted of patients with, on average,
different risk profiles. Multiple regression modeling can
never entirely account for these differences, and adjusted
effects may still be influenced by residual confounding.
However, if confounding was a serious problem, one would
expect unadjusted and adjusted estimates of the ORs to
differ quite markedly. Moreover, the risk of adverse out-
comes was consistently lower or not significantly different in
overweight and obese groups compared with the normal
weight group. The protective effects against mortality and
morbidity observed in obese patients may be optimistic, but
it is unlikely that residual confounding could reverse the
direction of these effects.
We are uncertain about the mechanism underlying the
apparent increase in the risk of poorer outcomes for under-
weight patients. The underweight group had, on average,
worse left ventricular function, was older, and had a higher
percentage of patients with diabetes and chronic obstructive
airways disease than the normal weight group. Statistical
adjustment for these differences may have been incomplete.
Variation in the risk of adverse outcomes for different
BMI groups. Many studies either have dichotomized pa-
tients into obese and non-obese groups, with varying cut-off
criteria for defining obesity (4–7,17), or have divided
patients into more than two groups on the basis of observed
centiles (18,19). Studies have also used different criteria for
inclusion; one considered only elective patients (7), and
three studies included patients undergoing heart valve repair
as well as CABG (4,6,20). With respect to the varying risk
of adverse outcomes for different BMI groups, however, it is
clear that ours is not the first study to contradict the
prevailing view that obesity is a risk factor for operative
mortality and morbidity following CABG (6,7,17,19) or to
Table 3. Adjusted ORs for Early Clinical Outcomes in Underweight, Normal Weight and Overweight Groups of Increasing BMI
Outcome
Underweight
(BMI <20) OR
(95% CI)*
Normal
Weight (BMI
>20 & <25)
OR (95% CI)*
Overweight (BMI
>25 & <30) OR
(95% CI)*
Obese (BMI >30
& <35) OR
(95% CI)*
Severely Obese
(BMI >35) OR
(95% CI)*
Death 4.12 (1.48 to 11.5) 1.00 (–) 1.31 (0.60 to 2.90) 1.12 (0.39 to 3.20)†
Perioperative MI 1.92 (0.62 to 5.96) 1.00 (–) 1.05 (0.60 to 1.83) 0.90 (0.44 to 1.88)†
Postoperative inotropic support 1.06 (0.73 to 1.56) 1.00 (–) 0.79 (0.67 to 0.92) 0.82 (0.67 to 1.00) 0.71 (0.49 to 1.02)
Postoperative IABP 2.10 (0.95 to 4.65) 1.00 (–) 1.06 (0.65 to 1.72) 0.78 (0.39 to 1.55)†
Postoperative arrhythmia 1.17 (0.73 to 1.86) 1.00 (–) 1.00 (0.81 to 1.23) 0.90 (0.67 to 1.20) 0.85 (0.50 to 1.43)
Postoperative VF or VT 1.10 (0.36 to 3.39) 1.00 (–) 0.64 (0.36 to 1.14) 0.41 (0.18 to 0.91)†
Pulmonary complication 1.55 (0.92 to 2.61) 1.00 (–) 1.03 (0.81 to 1.30) 1.17 (0.85 to 1.60) 1.16 (0.65 to 2.08)
Chest infection 1.14 (0.53 to 2.45) 1.00 (–) 1.03 (0.73 to 1.45) 1.08 (0.67 to 1.74) 0.80 (0.30 to 2.10)
Neurological complication 0.51 (0.12 to 2.25) 1.00 (–) 1.94 (1.17 to 3.21) 1.08 (0.51 to 2.30)†
Infective complication 2.78 (1.16 to 6.67) 1.00 (–) 1.76 (1.02 to 3.03) 2.65 (1.35 to 5.17) 2.17 (0.67 to 6.99)
Septicemia 4.44 (1.29 to 15.3) 1.00 (–) 1.71 (0.73 to 4.05) 3.43 (1.27 to 9.27)†
Renal complication 1.58 (0.83 to 3.02) 1.00 (–) 1.22 (0.85 to 1.74) 1.34 (0.82 to 2.22) 0.63 (0.21 to 1.86)
Reop. for bleeding tamponade 0.87 (0.36 to 2.15) 1.00 (–) 0.75 (0.52 to 1.09) 0.46 (0.25 to 0.84) 0.70 (0.26 to 1.88)
Blood loss 1,000 ml 0.99 (0.63 to 1.54) 1.00 (–) 0.79 (0.66 to 0.95) 0.61 (0.47 to 0.79) 0.41 (0.24 to 0.70)
Red blood cell transfusion 1.12 (0.73 to 1.72) 1.00 (–) 0.86 (0.72 to 1.02) 0.78 (0.62 to 0.99) 0.66 (0.43 to 1.00)
Total platelet transfusion 0.81 (0.47 to 1.37) 1.00 (–) 0.61 (0.48 to 0.76) 0.47 (0.34 to 0.67) 0.49 (0.24 to 0.99)
Fresh frozen plasma transfusion 1.30 (0.74 to 2.27) 1.00 (–) 0.72 (0.56 to 0.91) 0.48 (0.32 to 0.72) 0.43 (0.18 to 1.04)
Postoperative hemoglobin 10 g/dl 0.97 (0.63 to 1.50) 1.00 (–) 1.02 (0.85 to 1.21) 1.22 (0.97 to 1.54) 1.48 (0.99 to 2.22)
Ventilated 10 h 1.50 (1.02 to 2.21) 1.00 (–) 0.87 (0.74 to 1.02) 0.96 (0.78 to 1.19) 1.19 (0.81 to 1.73)
ITU stay 1 night 1.37 (0.91 to 2.07) 1.00 (–) 1.03 (0.86 to 1.23) 1.01 (0.80 to 1.29) 1.22 (0.81 to 1.84)
ITU & HDU stay 2 nights 0.80 (0.54 to 1.17) 1.00 (–) 1.00 (0.86 to 1.16) 0.97 (0.79 to 1.18) 1.17 (0.81 to 1.68)
Total length of stay 7 days‡ 1.60 (1.06 to 2.35) 1.00 (–) 1.20 (1.02 to 1.42) 1.40 (1.12 to 1.74) 1.50 (1.02 to 2.21)
*Odds ratios based on a logistic regression model, stratified by consultant team and adjusting for the five propensity scores (see text). Normal weight was the reference group in
all analyses. †The two highest BMI groups were combined for the logistic regression analysis because of the small number of events in the highest BMI group. ‡Excluding length
of stay for 21 patients who died in hospital.
BMI  body mass index; HDU  high dependency unit; IABP  intraaortic balloon pump; ITU  intensive therapy unit; MI  myocardial infarction; OR  odds ratio;
RBC  red blood cells; VF  ventricular fibrillation; VT  ventricular tachycardia.
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conclude that obesity may be protective against some
adverse outcomes (8,18).
We identified only one previous study that estimated the
risk of operative morbidity and mortality in a defined “low
weight” group, i.e., separating a “lower-than-normal”
weight group (BMI 20 kg/m2) from a normal weight
group (BMI 20 and 25 kg/m2) (20). This study also
found that underweight patients had an increased risk of
mortality and morbidity. A further study found that “low”
BMI was an independent predictor of mortality and mor-
bidity but took no account of differences in case-mix (8).
Our study has quantified the independent and important
role of low weight (BMI 20 kg/m2) as a predictor of
perioperative death and major complications compared with
normal weight, after adjusting for case-mix. We conclude
that the increased risk of adverse outcomes in lower weight
patients is largely confined to those who are underweight.
One of our striking findings was that, compared to the
normal weight group, overweight and obese groups were
significantly less likely to experience excessive postoperative
bleeding (1,000 ml) and to require transfusion of platelets
or fresh frozen plasma. This result is counterintuitive but is
consistent with those of other studies (8,18). A further study
found that obese patients (30 kg/m2) had a decreased risk
of reexploration for bleeding (20).
Persistence of belief that obesity is a risk factor for
mortality and morbidity after CABG. There are at least
three possible reasons obesity is still considered to be an
important risk factor for morbidity following CABG:
1) the “power” and influence of analyses from national
databases (5) and perceived methodological problems
with single center studies;
2) the inclusion of obesity in the Parsonnet score (4);
3) the difficulty for physicians in partitioning the complex
effects of other risk factors that may often be associated
with obesity.
What is clear from our own analysis and those of others
is: 1) it is not sufficient simply to compare obese and
Figure 1. The effect of body mass index (BMI) on perioperative death, postoperative complications, and postoperative blood loss following coronary artery
bypass grafting. Unadjusted (closed circles) and adjusted (open circles) odds ratios and 95% confidence intervals for underweight and overweight groups
of increasing BMI compared with a normal weight group. *For hospital death, the two highest BMI categories were combined for analysis.
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non-obese groups; and 2) adjustment for case-mix may be
critically important, given the imbalances in other important
prognostic factors that are often observed with varying
BMI. Ironically, obesity may have been erroneously in-
cluded in the Parsonnet risk scoring system because the
coefficient (i.e., ln[odds ratio]) for morbid obesity in the
published multiple logistic regression was significantly less
than zero (i.e., significantly protective against mortality) (4).
It is notable that obesity is included neither in the more
recent EuroSCORE risk stratification method (21) nor in
the New Zealand priority scoring system (22). Consider-
ation of these factors and findings of previous studies and
our own lead us to conclude that obesity is truly not a risk
factor for mortality and morbidity following CABG.
Under-representation of obese patients with severe isch-
emic heart disease. We found that obese patients under-
going CABG were more likely to be female, diabetic, and
hypertensive, as did many other studies (7,8,17,19,20).
However, the data for our institution suggest that obese
patients accepted for surgery have a more favorable risk
profile in other respects, i.e., less extensive coronary disease,
better left ventricular function, and less likely to have urgent
or emergency surgery compared with normal weight
patients.
Other studies have also found major imbalances in the
distribution of the extent of coronary disease and comor-
bidity among BMI groups, with almost every one finding
obese patients undergoing CABG or other cardiac surgery
procedures to be younger, on average, than non-obese
patients (6–8,17,18,20). Some studies have shown similar
patterns for other risk factors to the ones we observed
(7,8,17,18). Other studies failed to find or did not report
major imbalances between obese and non-obese patients in
the distribution of the extent of coronary disease (% left
main stem stenosis or number of diseased coronary vessels)
and left ventricular function (7,16,20).
There are two possible reasons for the imbalances we
observed. First, obese patients may die younger without
developing severe disease. If so, one would expect similar
imbalances across BMI groups in different institutions
because the etiology and progression of ischemic heart
disease is the same across the developed world. This could
explain why obese patients undergoing CABG in our study
were, on average, younger than patients with normal weight
but not why they had less severe ischemic heart disease.
Second, cardiologists or cardiac surgeons may tend to select
obese patients for surgery in a different way than they do
non-obese patients, i.e., they may be less likely to consider
obese than normal weight patients for surgery when they have
less favorable risk profiles. Inadvertent discrimination of this
kind against obese patients could arise because of the prevailing
view that obesity is a risk factor for mortality and morbidity
following CABG. If this is the main reason, then differences in
imbalances in prognostic factors between institutions might be
expected, dependent on the precise criteria used by cardiolo-
gists or cardiac surgeons to select patients for surgery.
Conclusions. Obesity does not increase the risk of periop-
erative death and other adverse outcomes in patients under-
going CABG. Underweight patients, in contrast, do appear
to have a higher risk of death and complications and to
recover from surgery more slowly. There is a need to
investigate reasons for the increased risk of adverse out-
comes in patients who are underweight. Interventions to
modify the risks of adverse outcomes should be evaluated by
randomized, controlled trials.
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